Base de dados : MEDLINE
Pesquisa : N02.278.035.128.800 [Categoria DeCS]
Referências encontradas : 4901 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 491 ir para página                         

  1 / 4901 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
[PMID]:29389091
[Au] Autor:Wickersham ME; Basey S
[Ti] Título:Is Accreditation Sufficient? A Case Study and Argument for Transparency when Government Regulatory Authority is Delegated.
[So] Source:J Health Hum Serv Adm;39(2):245-82, 2016.
[Is] ISSN:1079-3739
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Acreditação
Delegação Vertical de Responsabilidades Profissionais
Regulamentação Governamental
Transtornos Relacionados ao Uso de Opioides/terapia
Qualidade da Assistência à Saúde
Centros de Tratamento de Abuso de Substâncias/normas
[Mh] Termos MeSH secundário: Georgia
Seres Humanos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180227
[Lr] Data última revisão:
180227
[Sb] Subgrupo de revista:H
[Da] Data de entrada para processamento:180202
[St] Status:MEDLINE


  2 / 4901 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29206947
[Au] Autor:DeRigne LA; Burki A; Stoddard-Dare P
[Ad] Endereço:School of Social Work, Florida Atlantic University, 777 Glades Road, Boca Raton, FL 33431; Life of Purpose Treatment Center, Boca Raton, FL. Cleveland State University.
[Ti] Título:Academic Disruption and Substance Use Disorders: University-Based Treatment Facilities.
[So] Source:Health Soc Work;41(3):201-204, 2016 Aug 01.
[Is] ISSN:0360-7283
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Estudantes/psicologia
Centros de Tratamento de Abuso de Substâncias/organização & administração
Transtornos Relacionados ao Uso de Substâncias/terapia
Universidades
[Mh] Termos MeSH secundário: Adolescente
Feminino
Seres Humanos
Masculino
Modelos Organizacionais
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180227
[Lr] Data última revisão:
180227
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171206
[St] Status:MEDLINE
[do] DOI:10.1093/hsw/hlw020


  3 / 4901 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27776681
[Au] Autor:Huynh C; Tremblay J; Fleury MJ
[Ad] Endereço:Institut universitaire sur les dépendances, Centre intégré universitaire de santé et de services sociaux du Centre-Sud-de-l'Île-de-Montréal, 950 Louvain Est, Montréal, Québec, Canada H2M 2E8; McGill University, Douglas Mental Health University Institute, 6875 LaSalle Boulevard, Montréal, Québec, Canada H4H 1R3. Electronic address: christophe.huynh.crdm@ssss.gouv.qc.ca.
[Ti] Título:Typologies of Individuals Attending an Addiction Rehabilitation Center Based on Diagnosis of Mental Disorders.
[So] Source:J Subst Abuse Treat;71:68-78, 2016 12.
[Is] ISSN:1873-6483
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:OBJECTIVES: This study aimed to: (1) identify clusters based on the diagnostic status of mental disorders among individuals with problematic substance use treated in an addiction rehabilitation center (ARC), and (2) characterize these clusters according to socio-demographic variables, neighborhood characteristics, and health service utilization. METHODS: Data were compiled for 4526 individuals with problematic substance use who received services from an ARC in 2004. The data were compiled by merging four databases: the ARC data registry, the Quebec Health Insurance Board database, the Quebec provincial database for hospitalizations, and the Quebec National Institute of Public Health database. A two-step cluster analysis was performed to generate distinct groups based on diagnostic categories of mental disorders. Complementary comparative analyses were conducted to test differences among the clusters. RESULTS: Three clusters were identified. The first cluster consisted of individuals who did not receive any diagnosis of a mental disorder, including substance use disorders (SUDs), and who were low users of health services. The second cluster was composed of individuals who received a diagnosis of mental disorder, but not of SUD, and who primarily used mental health services. The third cluster included individuals who had a dual diagnosis (co-occurring SUD and mental disorder), and who were high users of acute care services. CONCLUSIONS: This study highlights the heterogeneity of individuals with problematic substance use treated in an ARC. Treatment will be more effective, overall, if tailored to the varying needs of individuals with problematic substance use. Recommendations of the study geared toward improving the effectiveness of care for this population include systematic diagnostic screening for SUDs by physicians, developing strong primary care for individuals with problematic substance use, and ensuring a continuing care model for individuals with a dual diagnosis.
[Mh] Termos MeSH primário: Transtornos Mentais/epidemiologia
Serviços de Saúde Mental/estatística & dados numéricos
Pessoas Mentalmente Doentes/estatística & dados numéricos
Sistema de Registros/estatística & dados numéricos
Centros de Tratamento de Abuso de Substâncias/estatística & dados numéricos
Transtornos Relacionados ao Uso de Substâncias/epidemiologia
[Mh] Termos MeSH secundário: Adulto
Comorbidade
Feminino
Seres Humanos
Masculino
Transtornos Mentais/terapia
Serviços de Saúde Mental/utilização
Pessoas Mentalmente Doentes/classificação
Meia-Idade
Quebeque/epidemiologia
Centros de Tratamento de Abuso de Substâncias/utilização
Transtornos Relacionados ao Uso de Substâncias/terapia
[Pt] Tipo de publicação:JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Em] Mês de entrada:1712
[Cu] Atualização por classe:180215
[Lr] Data última revisão:
180215
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:161026
[St] Status:MEDLINE


  4 / 4901 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27776674
[Au] Autor:Dugosh KL; Festinger DS; Lipkin JL
[Ad] Endereço:Treatment Research Institute, 600 Public Ledger Building, 150 S. Independence Mall West, Philadelphia, PA 19106, United States. Electronic address: kdugosh@tresearch.org.
[Ti] Título:Identifying and Addressing the Unmet Health Care Needs of Drug Court Clients.
[So] Source:J Subst Abuse Treat;71:30-35, 2016 12.
[Is] ISSN:1873-6483
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Drug courts address issues such as employment and housing but largely miss the opportunity to address important health care issues. The current study examined the prevalence and correlates of chronic medical conditions among a sample of drug court clients who were participating in a clinical trial of an intervention to reduce HIV risk. A total of 256 clients completed a health survey at entry into the drug court program and 9 months post-entry. The baseline health survey included a comprehensive list of chronic medical conditions, and participants were asked to indicate which, if any, they had ever been diagnosed as having. They were also asked to indicate whether or not they were currently receiving treatment for each chronic condition that they endorsed. The follow-up survey was identical to the baseline survey, with the exception that it contained items reflecting (1) whether or not any member of the drug court team engaged in discussion with the client about each of the chronic conditions reported and (2) whether the client received a referral to medical care for endorsed conditions while in the drug court program. Results indicated that over 50% of clients reported at least one chronic condition and 21% reported more than one condition. Among those with chronic conditions, 71% reported having chronic conditions for which they were not currently receiving treatment. Unfortunately, drug court clients reported that the drug court team did little to address these unmet health needs. Findings from this study suggest that clients could benefit if drug court programs began to widen their focus to include addressing health-related issues.
[Mh] Termos MeSH primário: Doença Crônica/terapia
Satisfação do Paciente
Centros de Tratamento de Abuso de Substâncias/normas
Transtornos Relacionados ao Uso de Substâncias/terapia
[Mh] Termos MeSH secundário: Adulto
Doença Crônica/epidemiologia
Comorbidade
Criminosos
Feminino
Seguimentos
Seres Humanos
Masculino
Prevalência
Centros de Tratamento de Abuso de Substâncias/legislação & jurisprudência
Transtornos Relacionados ao Uso de Substâncias/epidemiologia
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE; RESEARCH SUPPORT, N.I.H., EXTRAMURAL
[Em] Mês de entrada:1712
[Cu] Atualização por classe:180215
[Lr] Data última revisão:
180215
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:161026
[St] Status:MEDLINE


  5 / 4901 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28460232
[Au] Autor:Eddie D; Kelly JF
[Ad] Endereço:Recovery Research Institute, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, United States. Electronic address: deddie@mgh.harvard.edu.
[Ti] Título:How many or how much? Testing the relative influence of the number of social network risks versus the amount of time exposed to social network risks on post-treatment substance use.
[So] Source:Drug Alcohol Depend;175:246-253, 2017 06 01.
[Is] ISSN:1879-0046
[Cp] País de publicação:Ireland
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Having high-risk, substance-using friends is associated with young adult substance use disorder (SUD) relapse. It is unclear, however, whether it is the total number of high-risk friends, or the amount of time spent with high-risk friends that leads to relapse. Unclear also, is to what extent low-risk friends buffer risk. This study examined the influence of number of high-risk and low-risk friends, and the amount time spent with these friends on post-treatment percent days abstinent (PDA). METHOD: Young adult inpatients (N=302) were assessed at intake, and 3, 6, and 12 months on social network measures and PDA. Mixed models tested for effects of number of high- and low-risk friends, and time spent with these friends on PDA, and for net-risk friend effects to test whether low-risk friends offset risk. RESULTS: Within and across assessments, number of, and time spent with high-risk friends was negatively associated with PDA, while the inverse was true for low-risk friends. Early post-treatment, time spent with friends more strongly predicted PDA than number of friends. Participants were more deleteriously affected by time with high-risk friends the longer they were out of treatment, while contemporaneously protection conferred by low-risk friends increased. This interaction effect, however, was not observed with number of high- or low-risk friends, or number of friends net-risk. CONCLUSIONS: Young adult SUD patients struggling to break ties with high-risk friends should be encouraged to minimize time with them. Clinicians should also encourage patients to grow their social network of low-risk friends.
[Mh] Termos MeSH primário: Amigos/psicologia
Assunção de Riscos
Apoio Social
Transtornos Relacionados ao Uso de Substâncias/psicologia
Fatores de Tempo
[Mh] Termos MeSH secundário: Adulto
Feminino
Seres Humanos
Masculino
Centros de Tratamento de Abuso de Substâncias/estatística & dados numéricos
Transtornos Relacionados ao Uso de Substâncias/terapia
Resultado do Tratamento
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE; RESEARCH SUPPORT, N.I.H., EXTRAMURAL; RESEARCH SUPPORT, NON-U.S. GOV'T
[Em] Mês de entrada:1801
[Cu] Atualização por classe:180123
[Lr] Data última revisão:
180123
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170502
[St] Status:MEDLINE


  6 / 4901 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28640718
[Au] Autor:John T
[Ad] Endereço:Inpatient Quality & Development Lead, Kent and Medway NHS and Social Care Partnership Trust.
[Ti] Título:Setting up recovery clinics and promoting service user involvement.
[So] Source:Br J Nurs;26(12):671-676, 2017 Jun 22.
[Is] ISSN:0966-0461
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:Service user involvement in mental health has gained considerable momentum. Evidence from the literature suggests that it remains largely theoretical rather than being put into practice. The current nature of acute inpatient mental health units creates various challenges for nurses to put this concept into practice. Recovery clinics were introduced to bridge this gap and to promote service user involvement practice within the current care delivery model at Kent and Medway NHS and Social Care Partnership Trust. It has shaped new ways of working for nurses with a person-centred approach as its philosophy. Service users and nurses were involved in implementing a needs-led and bottom-up initiative using Kotter's change model. Initial results suggest that it has been successful in meeting its objectives evidenced through increased meaningful interactions and involvement in care by service users and carers. The clinics have gained wide recognition and have highlighted a need for further research into care delivery models to promote service user involvement in these units.
[Mh] Termos MeSH primário: Serviços de Saúde Mental/organização & administração
Participação do Paciente/psicologia
Assistência Centrada no Paciente/organização & administração
Autocuidado/psicologia
Medicina Estatal/organização & administração
Centros de Tratamento de Abuso de Substâncias/organização & administração
[Mh] Termos MeSH secundário: Seres Humanos
Cultura Organizacional
Objetivos Organizacionais
Reino Unido
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1708
[Cu] Atualização por classe:170821
[Lr] Data última revisão:
170821
[Sb] Subgrupo de revista:N
[Da] Data de entrada para processamento:170623
[St] Status:MEDLINE
[do] DOI:10.12968/bjon.2017.26.12.671


  7 / 4901 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28621658
[Au] Autor:Strike C; Miskovic M
[Ad] Endereço:Professor, Dalla Lana School of Public Health, University of Toronto; Affiliate Scientist, Centre for Addiction and Mental Health, Toronto, ON. carol.strike@utoronto.ca.
[Ti] Título:Zoning out methadone and rising opioid-related deaths in Ontario: Reforms and municipal government actions.
[So] Source:Can J Public Health;108(2):e205-e207, 2017 Jun 16.
[Is] ISSN:1920-7476
[Cp] País de publicação:Canada
[La] Idioma:eng
[Ab] Resumo:In this commentary, we argue that the use of amendments to bylaws by Ontario cities and municipalities to restrict where and how methadone maintenance treatment (MMT) clinics and pharmacies operate may run counter to efforts to prevent record high rates of opioid-related overdoses. As the province of Ontario seeks to reform the opioid treatment system, it is crucial to understand the structural (e.g., stigma) and treatment system organization factors that drive the actions of municipalities such as those described above. Changes that exacerbate these factors may lead to increased use of bylaws to curtail access at a time when efforts are underway to reduce alarming rates of opioid-related overdose.
[Mh] Termos MeSH primário: Analgésicos Opioides/envenenamento
Overdose de Drogas/mortalidade
Overdose de Drogas/prevenção & controle
Regulamentação Governamental
Governo Local
Metadona/uso terapêutico
Tratamento de Substituição de Opiáceos
[Mh] Termos MeSH secundário: Reforma dos Serviços de Saúde
Seres Humanos
Ontário/epidemiologia
Farmácias/legislação & jurisprudência
Estereotipagem
Centros de Tratamento de Abuso de Substâncias/legislação & jurisprudência
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Analgesics, Opioid); UC6VBE7V1Z (Methadone)
[Em] Mês de entrada:1708
[Cu] Atualização por classe:170809
[Lr] Data última revisão:
170809
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170617
[St] Status:MEDLINE
[do] DOI:10.17269/cjph.108.5858


  8 / 4901 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28586356
[Au] Autor:Zhou K; Wang D; Li H; Wei X; Yin J; Liang P; Kou L; Hao M; You L; Li X; Zhuang G
[Ad] Endereço:Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
[Ti] Título:Bidirectional relationships between retention and health-related quality of life in Chinese mainland patients receiving methadone maintenance treatment.
[So] Source:PLoS One;12(6):e0179009, 2017.
[Is] ISSN:1932-6203
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:This study aimed to explore the bidirectional relationships between retention and health-related quality of life (HRQoL) in patients from mainland China receiving methadone maintenance treatment (MMT). This prospective cohort study recruited 1,212 eligible MMT patients from the two largest MMT clinics (one privately and another publicly funded) in Xi'an. This study started in March 2012 with a 2-year follow-up until March 2014. Retention was assessed by repeated terminations, past treatment duration, premature terminations, and follow-up treatment duration. HRQoL was evaluated using the Chinese (simple) short-form 36 health survey version 2 (SF-36v2) and the quality of life scale for drug addicts (QOL-DAv2.0). Linear and Cox regression analyses were used to explore relationships between retention and HRQoL. A general linear model was used to further examine the global effect of past treatment duration on HRQoL. Multivariate analyses showed that repeated terminations had no significant impact on HRQoL scores in MMT patients; however, past treatment time (year) influenced the SF-36v2PCS (P = 0.004): treatment for ≥4 years showed a lower SF-36v2PCS score (regression coefficient: -2.39; 95% confidence interval [CI]: -3.80, -0.97; P = 0.001) than treatment for <1 year. In addition, patients with an SF-36v2PCS score > 49 (hazard ratio: 0.83; 95% CI: 0.69, 0.98; P = 0.03) were 17% less likely to terminate MMT than those with scores of ≤49. In conclusion, retention and HRQoL tended to have a bidirectional relationship, which should be considered in the development of retention and health-management programs for patients with MMT.
[Mh] Termos MeSH primário: Usuários de Drogas
Dependência de Heroína/tratamento farmacológico
Metadona/uso terapêutico
[Mh] Termos MeSH secundário: Adolescente
Adulto
Idoso
Criança
China
Feminino
Heroína/toxicidade
Dependência de Heroína/patologia
Dependência de Heroína/urina
Seres Humanos
Masculino
Metadona/efeitos adversos
Metadona/urina
Meia-Idade
Análise Multivariada
Tratamento de Substituição de Opiáceos/efeitos adversos
Modelos de Riscos Proporcionais
Qualidade de Vida
Centros de Tratamento de Abuso de Substâncias
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
70D95007SX (Heroin); UC6VBE7V1Z (Methadone)
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170919
[Lr] Data última revisão:
170919
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170607
[St] Status:MEDLINE
[do] DOI:10.1371/journal.pone.0179009


  9 / 4901 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28219965
[Au] Autor:Patrick SW; Schiff DM; COMMITTEE ON SUBSTANCE USE AND PREVENTION
[Ti] Título:A Public Health Response to Opioid Use in Pregnancy.
[So] Source:Pediatrics;139(3), 2017 Mar.
[Is] ISSN:1098-4275
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:The use of opioids during pregnancy has grown rapidly in the past decade. As opioid use during pregnancy increased, so did complications from their use, including neonatal abstinence syndrome. Several state governments responded to this increase by prosecuting and incarcerating pregnant women with substance use disorders; however, this approach has no proven benefits for maternal or infant health and may lead to avoidance of prenatal care and a decreased willingness to engage in substance use disorder treatment programs. A public health response, rather than a punitive approach to the opioid epidemic and substance use during pregnancy, is critical, including the following: a focus on preventing unintended pregnancies and improving access to contraception; universal screening for alcohol and other drug use in women of childbearing age; knowledge and informed consent of maternal drug testing and reporting practices; improved access to comprehensive obstetric care, including opioid-replacement therapy; gender-specific substance use treatment programs; and improved funding for social services and child welfare systems. The American College of Obstetricians and Gynecologists supports the value of this clinical document as an educational tool (December 2016).
[Mh] Termos MeSH primário: Transtornos Relacionados ao Uso de Opioides/prevenção & controle
Complicações na Gravidez/prevenção & controle
[Mh] Termos MeSH secundário: Criança
Defesa da Criança e do Adolescente/legislação & jurisprudência
Bem-Estar da Criança/legislação & jurisprudência
Feminino
Acesso aos Serviços de Saúde
Seres Humanos
Recém-Nascido
Transtornos Relacionados ao Uso de Opioides/diagnóstico
Gravidez
Complicações na Gravidez/diagnóstico
Cuidado Pré-Natal
Prevenção Primária
Detecção do Abuso de Substâncias
Centros de Tratamento de Abuso de Substâncias
Estados Unidos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1706
[Cu] Atualização por classe:170630
[Lr] Data última revisão:
170630
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170222
[St] Status:MEDLINE


  10 / 4901 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28207902
[Au] Autor:Lea T; Kolstee J; Lambert S; Ness R; Hannan S; Holt M
[Ad] Endereço:Centre for Social Research in Health, UNSW Australia, Sydney, New South Wales, Australia.
[Ti] Título:Methamphetamine treatment outcomes among gay men attending a LGBTI-specific treatment service in Sydney, Australia.
[So] Source:PLoS One;12(2):e0172560, 2017.
[Is] ISSN:1932-6203
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Gay and bisexual men (GBM) report higher rates of methamphetamine use compared to heterosexual men, and thus have a heightened risk of developing problems from their use. We examined treatment outcomes among GBM clients receiving outpatient counseling at a lesbian, gay, bisexual, transgender and intersex (LGBTI)-specific, harm reduction treatment service in Sydney, Australia. GBM receiving treatment for methamphetamine use from ACON's Substance Support Service between 2012-15 (n = 101) were interviewed at treatment commencement, and after 4 sessions (n = 60; follow-up 1) and 8 sessions (n = 32; follow-up 2). At each interview, clients completed measures of methamphetamine use and dependence, other substance use, injecting risk practices, psychological distress and quality of life. The median age of participants was 41 years and 56.4% identified as HIV-positive. Participants attended a median of 5 sessions and attended treatment for a median of 112 days. There was a significant reduction in the median days of methamphetamine use in the previous 4 weeks between baseline (4 days), follow-up 1 (2 days) and follow-up 2 (2 days; p = .001). There was a significant reduction in the proportion of participants reporting methamphetamine dependence between baseline (92.1%), follow-up 1 (78.3%) and follow-up 2 (71.9%, p < .001). There were also significant reductions in psychological distress (p < .001), and significant improvements in quality of life (p < .001). Clients showed reductions in methamphetamine use and improved psychosocial functioning over time, demonstrating the potential effectiveness of a LGBTI-specific treatment service.
[Mh] Termos MeSH primário: Transtornos Relacionados ao Uso de Anfetaminas/epidemiologia
Transtornos Relacionados ao Uso de Anfetaminas/terapia
Estimulantes do Sistema Nervoso Central/uso terapêutico
Metanfetamina/uso terapêutico
Qualidade de Vida
Centros de Tratamento de Abuso de Substâncias/utilização
[Mh] Termos MeSH secundário: Adulto
Assistência Ambulatorial
Transtornos Relacionados ao Uso de Anfetaminas/psicologia
Austrália/epidemiologia
Bissexualidade
Feminino
Homossexualidade Masculina/psicologia
Seres Humanos
Masculino
Meia-Idade
Comportamento Sexual
Pessoas Transgênero
Resultado do Tratamento
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Central Nervous System Stimulants); 44RAL3456C (Methamphetamine)
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170901
[Lr] Data última revisão:
170901
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170217
[St] Status:MEDLINE
[do] DOI:10.1371/journal.pone.0172560



página 1 de 491 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde